<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Nasdaq Trade System - Atara Biotherapeutics, Inc. - Common Stock</title>
    <!-- Latest compiled and minified CSS -->
    <link href="https://cdn.jsdelivr.net/npm/bootstrap@5.3.6/dist/css/bootstrap.min.css" rel="stylesheet"
          integrity="sha384-4Q6Gf2aSP4eDXB8Miphtr37CMZZQ5oXLH2yaXMJ2w8e2ZtHTl7GptT4jmndRuHDT" crossorigin="anonymous">
    <script src="https://cdn.jsdelivr.net/npm/bootstrap@5.3.6/dist/js/bootstrap.bundle.min.js"
            integrity="sha384-j1CDi7MgGQ12Z7Qab0qlWQ/Qqz24Gc6BM0thvEMVjHnfYGF0rmFCozFSxQBxwHKO"
            crossorigin="anonymous"></script>
    <meta name="theme-color" content="#712cf9">
</head>

<body>
<header class="navbar sticky-top bg-dark flex-md-nowrap p-0 shadow" data-bs-theme="dark"><a
        class="navbar-brand col-md-3 col-lg-2 me-0 px-3 fs-6 text-white" href="#">Nasdaq Trade system</a>
</header>


<div class="container-fluid">
    <div class="row">

        <main class="col-md-9 ms-sm-auto col-lg-10 px-md-4">
            <a href="../GameResult.html">Back</a>
            <h1>Atara Biotherapeutics, Inc. - Common Stock</h1>
            <img src="ATRA.png" class="img-fluid">
            
            <div class="table-responsive small">
                <table class="table table-striped table-sm">
                    <thead>
                    <tr>
                        <th scope="col">ExecutedOn</th>
                        <th scope="col">Company</th>
                        <th scope="col">Listing</th>
                        <th scope="col">Amount</th>
                        <th scope="col">AtPrice</th>
                        <th scope="col">Total</th>
                    </tr>
                    </thead>
                    <tbody>
                    <tr scope="row">
                        <td>13-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>3</td>
                        <td>$355.75</td>
                        <td>$1,067.25</td>
                    </tr>
                    <tr scope="row">
                        <td>14-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-3</td>
                        <td>$401.75</td>
                        <td>-$1,205.25</td>
                    </tr>
                    <tr scope="row">
                        <td>24-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>3</td>
                        <td>$366.50</td>
                        <td>$1,099.50</td>
                    </tr>
                    <tr scope="row">
                        <td>25-01-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-3</td>
                        <td>$377.50</td>
                        <td>-$1,132.50</td>
                    </tr>
                    <tr scope="row">
                        <td>07-03-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>15</td>
                        <td>$214.75</td>
                        <td>$3,221.25</td>
                    </tr>
                    <tr scope="row">
                        <td>08-03-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-15</td>
                        <td>$225.00</td>
                        <td>-$3,375.00</td>
                    </tr>
                    <tr scope="row">
                        <td>02-06-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>169</td>
                        <td>$120.75</td>
                        <td>$20,406.75</td>
                    </tr>
                    <tr scope="row">
                        <td>03-06-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-169</td>
                        <td>$128.50</td>
                        <td>-$21,716.50</td>
                    </tr>
                    <tr scope="row">
                        <td>06-06-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>168</td>
                        <td>$129.75</td>
                        <td>$21,798.00</td>
                    </tr>
                    <tr scope="row">
                        <td>07-06-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-168</td>
                        <td>$141.75</td>
                        <td>-$23,814.00</td>
                    </tr>
                    <tr scope="row">
                        <td>28-06-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>215</td>
                        <td>$163.75</td>
                        <td>$35,206.25</td>
                    </tr>
                    <tr scope="row">
                        <td>29-06-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-215</td>
                        <td>$189.50</td>
                        <td>-$40,742.50</td>
                    </tr>
                    <tr scope="row">
                        <td>29-06-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>215</td>
                        <td>$189.50</td>
                        <td>$40,742.50</td>
                    </tr>
                    <tr scope="row">
                        <td>30-06-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-215</td>
                        <td>$194.75</td>
                        <td>-$41,871.25</td>
                    </tr>
                    <tr scope="row">
                        <td>30-06-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>215</td>
                        <td>$194.75</td>
                        <td>$41,871.25</td>
                    </tr>
                    <tr scope="row">
                        <td>01-07-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-215</td>
                        <td>$207.50</td>
                        <td>-$44,612.50</td>
                    </tr>
                    <tr scope="row">
                        <td>11-07-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>267</td>
                        <td>$185.00</td>
                        <td>$49,395.00</td>
                    </tr>
                    <tr scope="row">
                        <td>12-07-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-267</td>
                        <td>$216.50</td>
                        <td>-$57,805.50</td>
                    </tr>
                    <tr scope="row">
                        <td>08-08-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>1000</td>
                        <td>$90.75</td>
                        <td>$90,750.00</td>
                    </tr>
                    <tr scope="row">
                        <td>09-08-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-1000</td>
                        <td>$117.25</td>
                        <td>-$117,250.00</td>
                    </tr>
                    <tr scope="row">
                        <td>11-08-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>1000</td>
                        <td>$116.25</td>
                        <td>$116,250.00</td>
                    </tr>
                    <tr scope="row">
                        <td>12-08-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-1000</td>
                        <td>$146.00</td>
                        <td>-$146,000.00</td>
                    </tr>
                    <tr scope="row">
                        <td>23-08-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>1000</td>
                        <td>$105.75</td>
                        <td>$105,750.00</td>
                    </tr>
                    <tr scope="row">
                        <td>24-08-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-1000</td>
                        <td>$115.00</td>
                        <td>-$115,000.00</td>
                    </tr>
                    <tr scope="row">
                        <td>31-08-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>1000</td>
                        <td>$100.25</td>
                        <td>$100,250.00</td>
                    </tr>
                    <tr scope="row">
                        <td>01-09-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-1000</td>
                        <td>$108.75</td>
                        <td>-$108,750.00</td>
                    </tr>
                    <tr scope="row">
                        <td>29-09-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>1000</td>
                        <td>$90.75</td>
                        <td>$90,750.00</td>
                    </tr>
                    <tr scope="row">
                        <td>30-09-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-1000</td>
                        <td>$94.50</td>
                        <td>-$94,500.00</td>
                    </tr>
                    <tr scope="row">
                        <td>01-12-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>1000</td>
                        <td>$110.00</td>
                        <td>$110,000.00</td>
                    </tr>
                    <tr scope="row">
                        <td>02-12-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Atara Biotherapeutics, Inc. - Common Stock</td>
                        <td>-1000</td>
                        <td>$119.00</td>
                        <td>-$119,000.00</td>
                    </tr>
                    </tbody>
                </table>
            </div>
        </main>
    </div>
</div>
</body>
</html>